Years of Research
One Powerful Active Ingredient
Unlimited Benefits for the Skin
CALECIM® Professional is developed from skin regeneration technology.
Scientists have discovered how proteins derived from Cord Lining Stem Cells are able to treat symptoms of aging.View Product Range
Studied in the Lab
Our Scientists believe that the active proteins derived from Cord Lining Stem Cells can trigger positive reactions by sending cellular messages to the skin.
These are evidence of skin renewal, rejuvenation and restoration when skin cells are exposed to Cord Lining Conditioned Media, as shown in-vitro.
growth at 7 days
in skin density
Accelerated skin restoration
These cellular messages work in tandem to activate skin cells to act in a more youthful manner. They are able to work on multiple signs of aging to achieve skin that is healthier, more resilient and radiant.
are incredibly important to us.
You can be confident that your decisions are based on scientific evidence.
Created by Scientists
Produced in a Stem Cell Lab
Trusted by Doctors
Validated by Patients
The World's Only Skincare
Cord Lining Stem Cells
CellResearch Corporation, is a biotechnology company that discovered the presence of stem cells in the umbilical cord lining 16 years ago.
CALECIM® Professional draws on its parent company’s patented stem cell knowledge currently being utilized in US FDA clinical trials
Two Types of Stem Cells:
It has been found that the Cord Lining is the richest source of stem cells from a non-embryonic source.
The combination of growth factors and proteins derived from both Mesenchymal and Epithelial Stem Cells is able to trigger cellular reactions from all layers of the skin, from the dermis to the epidermis.
The healing promise of mesenchymal stem cells seems not to lie in the cells themselves.
Rather, they produce beneficial cytokines – proteins essential to wound healing – and may act as a spur for the production of the key restorative factors.
A Stem Cell Trial For Diabetic Foot Ulcer, UCHealth Today.See full article about our parent company’s USFDA trial, in collaboration with University of Colorado:
Cord Lining Technology:
Skincare and Beyond
Our parent company, CellResearch Corporation, is committed to turning this critical scientific advancement into accessible consumer and medical products.
To this end, the company is leading extensive stem cell research across numerous fields of medicine, paving the way for potential therapeutic opportunities using Cord Lining Stem Cells.
Our technology can be applied to almost any medical field. With our yield of billions of stem cells, it means we can take advantage of the economy in numbers, and stem cell therapy may now finally be within reach of most, if not all.
To date, thousands of patients have benefited from these stem cell therapies in South East Asia.
The Create a Better World Initiative provided the therapies for these patients at highly subsidized rates or without charge.Learn more
Create a Better World:
Stem Cell Research Initiative
This initiative was launched in the early 2000s with the treatment of patients with chronic burns and wounds. Application of Cord Lining Stem Cells closed many of these wounds where conventional treatments had failed.